Latest debt-to-equity ratio

Arbutus Biopharma Debt-to-equity ratio

Direct answer

Arbutus Biopharma's debt-to-equity ratio is 1.4%.

The verified market snapshot reports 1.4%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.

Get free Arbutus Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
1.4%

Explore related company data

View Arbutus Biopharma's market capitalizationView Arbutus Biopharma's p/e ratioView Arbutus Biopharma's price-to-book ratioView Arbutus Biopharma's return on equityView Arbutus Biopharma's 52-week price rangeView Arbutus Biopharma's revenue growthView Arbutus Biopharma's profit marginView all Arbutus Biopharma key metricsReturn to Arbutus Biopharma profile